Reactogenicity and Concomitant Administration of the COVID-19 Booster and Influenza Vaccine

Kathryn T Hall^{1

2}, Valerie E Stone¹, Bisola Ojikutu^{1

2

3}

Affiliations

¹ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Boston Public Health Commission, Boston, Massachusetts.
³ Infectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts.

Free article

Comment

Kathryn T Hall et al. JAMA Netw Open. 2022.

Free article

. 2022 Jul 1;5(7):e2222246.

doi: 10.1001/jamanetworkopen.2022.22246.

Kathryn T Hall^{1

2}, Valerie E Stone¹, Bisola Ojikutu^{1

2

3}

¹ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Boston Public Health Commission, Boston, Massachusetts.
³ Infectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts.

No abstract available

Comment on

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
Hause AM, Zhang B, Yue X, Marquez P, Myers TR, Parker C, Gee J, Su J, Shimabukuro TT, Shay DK. Hause AM, et al. JAMA Netw Open. 2022 Jul 1;5(7):e2222241. doi: 10.1001/jamanetworkopen.2022.22241. JAMA Netw Open. 2022. PMID: 35838667 Free PMC article.